Asthma affects approximately 262 million people worldwide, driving a massive surge in demand for Asthma Control Technology. The global market is transitioning from traditional inhalers to connected digital ecosystems. Today's healthcare providers and B2B buyers are no longer just looking for hardware; they seek integrated solutions that combine IoT connectivity, AI diagnostics, and patient adherence tracking.
The industry has moved beyond prototypes. We are now in the "Smart Era" where wearable sensors and cloud-synced nebulizers are the standard for respiratory care management.
Global enterprises, particularly in North America and Europe, prioritize data privacy (HIPAA/GDPR) and seamless EMR integration when selecting manufacturers.
Technological advancement now allows for predictive alerts—notifying patients of potential attacks before they happen based on environmental and physiological data.
The 2024-2030 roadmap for Asthma Control Technology focuses on Miniaturization and Ubiquitous Monitoring. Factories are now integrating biometric sensors into everyday wearables, ensuring that patients are monitored without the stigma of traditional medical devices.
As a leading Chinese manufacturer, Met Health leverages the unmatched ecosystem of Shenzhen. Our advantage isn't just cost—it's Speed-to-Market and R&D Agility. While Western designs may take years to iterate, our integrated factory model allows us to move from concept to mass production in months.
Our facility ensures that every Asthma Control Device meets ISO9001 standards, providing the reliability required for medical-grade hardware while maintaining the scalability of consumer electronics.
Founded in 2015, Met Health has become a leading manufacturer specializing in smart wearable devices. With over a decade of expertise in research and development, production, and management, we focus on delivering innovative solutions in senior health management, disease monitoring, and personal safety.
Years of R&D
Units Monthly
9001 Certified
Custom Services
Our state-of-the-art production facility in Shenzhen is equipped with advanced production lines and precision equipment, ensuring high-quality manufacturing standards. As an ISO9001-certified company, we maintain stringent quality control throughout the production process.
With over a decade of experience in R&D and manufacturing, we specialize in providing innovative wearable solutions, particularly in senior health management, disease monitoring, and personal safety.
Our ISO9001-certified facility in Shenzhen is equipped with state-of-the-art production lines and precision equipment, ensuring consistent quality and reliability across all products.
We offer tailored OEM/ODM services, allowing us to deliver personalized solutions that meet the specific needs of our clients, supported by a strong supply chain for efficient delivery.
Integration with Medicare billing systems and remote patient monitoring (RPM) platforms for automated respiratory reports.
Implementation in "Aging in Place" initiatives where devices monitor airway health without intrusive nursing visits.
Large-scale monitoring in regions with high pollution indices, ensuring school nurses are alerted to student needs in real-time.
Modern buyers look for: Low Latency Connectivity, Battery Longevity, Biocompatible Materials, and White-Label Readiness. Met Health addresses these through a robust supply chain that guarantees cost efficiency and timely delivery of world-class wearable products.
Met Health
